GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SSB · Mar 31, 2026

SouthState Bank Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001104659-26-053548Bank
Sequential deposit growth65thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

1.32% · CORE · VALID

Net-income growth90thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

153.50% · CORE · VALID

Interest-income growth10thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

1.02% · CORE · VALID

Cash and equivalents50thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$2.9B · CORE · VALID

Sequential loan growth70thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

1.87% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History27 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
1.98%
Current
1.32%
Delta
-0.66%
Earnings Growth Increased
Previous
49.34%
Current
153.50%
Delta
104.16%
Interest Income Growth Decreased
Previous
57.82%
Current
1.02%
Delta
-56.80%
Liquidity Decreased
Previous
$3.2B
Current
$2.9B
Delta
-$305.4M
Loan Growth Decreased
Previous
1.99%
Current
1.87%
Delta
-0.12%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.